A carregar...
Deferasirox – a rarer cause of Fanconi syndrome
Deferasirox is a recently approved iron chelator and is widely used to treat iron overload in transfusion-dependent patients. Its once-daily dosing and oral route of administration have made it an appealing alternative to deferoxamine. Recent case studies have brought to light its potential to cause...
Na minha lista:
| Publicado no: | J Community Hosp Intern Med Perspect |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735296/ https://ncbi.nlm.nih.gov/pubmed/31528290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20009666.2019.1650592 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|